Computational strategies in Klebsiella pneumoniae vaccine design: navigating the landscape of in silico insights.
Biotechnology Advances, ISSN: 0734-9750, Vol: 76, Page: 108437
2024
- 3Citations
- 27Captures
- 1Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Most Recent News
Studies from University of Oxford Update Current Data on Klebsiella pneumoniae (Computational Strategies In Klebsiella Pneumoniae Vaccine Design: Navigating the Landscape of In Silico Insights)
2025 JAN 29 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Daily -- Investigators discuss new findings in Gram-Negative Bacteria - Klebsiella pneumoniae.
Review Description
The emergence of multidrug-resistant Klebsiella pneumoniae poses a grave threat to global public health, necessitating urgent strategies for vaccine development. In this context, computational tools have emerged as indispensable assets, offering unprecedented insights into klebsiellal biology and facilitating the design of effective vaccines. Here, a review of the application of computational methods in the development of K. pneumoniae vaccines is presented, elucidating the transformative impact of in silico approaches. Through a systematic exploration of bioinformatics, structural biology, and immunoinformatics techniques, the complex landscape of K. pneumoniae pathogenesis and antigenicity was unravelled. Key insights into virulence factors, antigen discovery, and immune response mechanisms are discussed, highlighting the pivotal role of computational tools in accelerating vaccine development efforts. Advancements in epitope prediction, antigen selection, and vaccine design optimisation are examined, highlighting the potential of in silico approaches to update vaccine development pipelines. Furthermore, challenges and future directions in leveraging computational tools to combat K. pneumoniae are discussed, emphasizing the importance of multidisciplinary collaboration and data integration. This review provides a comprehensive overview of the current state of computational contributions to K. pneumoniae vaccine development, offering insights into innovative strategies for addressing this urgent global health challenge.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0734975024001319; http://dx.doi.org/10.1016/j.biotechadv.2024.108437; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85202765332&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/39216613; https://linkinghub.elsevier.com/retrieve/pii/S0734975024001319
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know